Zobrazeno 1 - 10 of 425 pro vyhledávání: '"MC Béné"'
2
Surface markers in adult acute myeloblastic leukemia: correlation of CD19+, CD34+ and CD14+/DR--phenotypes with shorter survival. Groupe d'Etude Immunologique des Leucémies (GEIL)
Autor: Solary E, René-Olivier Casasnovas, Campos L, Mc, Béné, Faure G, Maingon P, Falkenrodt A, Lenormand B, Genetet N
Publikováno v: Europe PubMed Central
The immunophenotype of blast cells was investigated in a multicentric study of 154 adult acute myeloblastic leukemias (AMLs). A panel of 27 monoclonal antibodies (MoAbs) was tested in indirect immunofluorescence. Expression of CD14 (UCHM1), CD19 (SB4
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b48eb210c12032bbd5ee3d9396d8f38c
http://europepmc.org/abstract/med/1375696
Zobrazit plný text záznamu
3
Akademický článek
Purplish granules as a cytological signature of cortical developmental disorders caused by pathogenic variants in WDR81.
Autor: Le Calvez B; Pediatric Oncology, Nantes University Hospital, Nantes, France.; CRCI2NA, INSERM U1307, CNRS, Université d'Angers, Université de Nantes, Nantes, France., Besnard T; Genetics Department, Nantes University Hospital, Nantes, France., Cogne B; Genetics Department, Nantes University Hospital, Nantes, France., Bézieau S; Genetics Department, Nantes University Hospital, Nantes, France., Béné MC; CRCI2NA, INSERM U1307, CNRS, Université d'Angers, Université de Nantes, Nantes, France., Beneteau C; Genetics Department, Nantes University Hospital, Nantes, France.; Genetics Department, Bordeaux University Hospital, Bordeaux, France., Eveillard M; CRCI2NA, INSERM U1307, CNRS, Université d'Angers, Université de Nantes, Nantes, France.; Hematology Biology, Nantes University Hospital, Nantes, France.
Publikováno v: American journal of hematology [Am J Hematol] 2024 Nov; Vol. 99 (11), pp. 2215-2218. Date of Electronic Publication: 2024 Apr 17.
Zobrazit plný text záznamu
4
Akademický článek
Mepacrine Flow Cytometry Assay for the Diagnosis of Platelet δ-granule Defects: Literature Review on Methods-Towards a Shared Detailed Protocol.
Autor: Khourssaji M; Department of Laboratory Medicine, Hematology Laboratory, CHU UCL Namur, Yvoir, Belgium.; Institut de Recherche Expérimentale et Clinique (IREC) - Pôle Mont, Université catholique de Louvain, Yvoir, Belgium., Bareille M; Department of Laboratory Medicine, Hematology Laboratory, CHU UCL Namur, Yvoir, Belgium.; Institut de Recherche Expérimentale et Clinique (IREC) - Pôle Mont, Université catholique de Louvain, Yvoir, Belgium., Alberio L; Division of Haematology and Central Haematology Laboratory, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland., Borgel D; Service d'Hématologie Biologique, Hôpital Necker AP-HP, Paris, France., Fouassier M; Centre de Ressources et de Compétences - Maladies Hémorragiques Constitutionnelles, CHU de Nantes, Nantes, France., Béné MC; CRC2INA, Université de Nantes, Nantes, France., Lecompte T; Department of Laboratory Medicine, Hematology Laboratory, CHU UCL Namur, Yvoir, Belgium.; Hematology Department and Grand East Competence Center on Inherited Platelet Disorders, CHU Nancy, Nancy, France., Mullier F; Department of Laboratory Medicine, Hematology Laboratory, CHU UCL Namur, Yvoir, Belgium.; Institut de Recherche Expérimentale et Clinique (IREC) - Pôle Mont, Université catholique de Louvain, Yvoir, Belgium.; Université de Namur, Department of Pharmacy, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Namur, Belgium.
Publikováno v: Thrombosis and haemostasis [Thromb Haemost] 2024 Oct 24. Date of Electronic Publication: 2024 Oct 24.
Zobrazit plný text záznamu
5
Akademický článek
Morphology and multiparameter flow cytometry combined for integrated lymphoma diagnosis on small volume samples: possibilities and limitations.
Autor: Ehinger M; Division of Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden. mats.ehinger@med.lu.se.; Department of Clinical Genetics, Pathology and Molecular Diagnostics, Office for Medical Services, Region Skåne, Lund, Sweden. mats.ehinger@med.lu.se., Béné MC; Faculty of Medicine, Nantes University, Nantes, France.
Publikováno v: Virchows Archiv : an international journal of pathology [Virchows Arch] 2024 Oct; Vol. 485 (4), pp. 591-604. Date of Electronic Publication: 2024 May 28.
Zobrazit plný text záznamu
6
Akademický článek
Pre-graft vaccination or infection do not decrease COVID-19 infections in recipients of allogeneic stem cell transplantation vaccinated and/or protected by immunotherapy after transplant.
Autor: Letailleur V; Hematology Department, Nantes University Hospital, Nantes, France., Le Bourgeois A; Hematology Department, Nantes University Hospital, Nantes, France., Guillaume T; Hematology Department, Nantes University Hospital, Nantes, France.; INSERM UMR1232, CRCINA IRS-UN, University of Nantes, Nantes, France., Garnier A; Hematology Department, Nantes University Hospital, Nantes, France., Peterlin P; Hematology Department, Nantes University Hospital, Nantes, France., Jullien M; Hematology Department, Nantes University Hospital, Nantes, France., Antier C; Hematology Department, Nantes University Hospital, Nantes, France., Béné MC; Hematology Biology Department, Nantes University Hospital, Nantes, France., Chevallier P; Hematology Department, Nantes University Hospital, Nantes, France.; INSERM UMR1232, CRCINA IRS-UN, University of Nantes, Nantes, France.
Publikováno v: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2370970. Date of Electronic Publication: 2024 Jul 08.
Zobrazit plný text záznamu
7
Akademický článek
Low frequency of Vγ9Vδ2 T cells predicts poor survival in newly diagnosed acute myeloid leukemia.
Autor: Le Floch AC; Equipe Immunité et Cancer, Centre de Recherche en Cancérologie de Marseille, INSERM U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille Université, UM105, Marseille, France.; Plateforme d'immunomonitoring, Institut Paoli-Calmettes, Marseille, France., Orlanducci F; Equipe Immunité et Cancer, Centre de Recherche en Cancérologie de Marseille, INSERM U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille Université, UM105, Marseille, France.; Plateforme d'immunomonitoring, Institut Paoli-Calmettes, Marseille, France., Béné MC; Service d'Hématologie Biologique, CHU de Nantes, Nantes, France., Ben Amara A; Equipe Immunité et Cancer, Centre de Recherche en Cancérologie de Marseille, INSERM U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille Université, UM105, Marseille, France.; Plateforme d'immunomonitoring, Institut Paoli-Calmettes, Marseille, France., Rouviere MS; Equipe Immunité et Cancer, Centre de Recherche en Cancérologie de Marseille, INSERM U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille Université, UM105, Marseille, France.; Plateforme d'immunomonitoring, Institut Paoli-Calmettes, Marseille, France., Salem N; Equipe Immunité et Cancer, Centre de Recherche en Cancérologie de Marseille, INSERM U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille Université, UM105, Marseille, France.; Plateforme d'immunomonitoring, Institut Paoli-Calmettes, Marseille, France., Le Roy A; Equipe Immunité et Cancer, Centre de Recherche en Cancérologie de Marseille, INSERM U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille Université, UM105, Marseille, France.; Plateforme d'immunomonitoring, Institut Paoli-Calmettes, Marseille, France., Cordier C; Equipe Immunité et Cancer, Centre de Recherche en Cancérologie de Marseille, INSERM U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille Université, UM105, Marseille, France.; Plateforme d'immunomonitoring, Institut Paoli-Calmettes, Marseille, France., Demerlé C; Equipe Immunité et Cancer, Centre de Recherche en Cancérologie de Marseille, INSERM U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille Université, UM105, Marseille, France.; Plateforme d'immunomonitoring, Institut Paoli-Calmettes, Marseille, France., Granjeaud S; Systems Biology Platform, Centre de Recherche en Cancérologie de Marseille, INSERM U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille University UM105, Marseille, France., Hamel JF; Département de Biostatistiques, Centre Hospitalier Universitaire d'Angers, Université d'Angers, Angers, France., Ifrah N; Département d'Hématologie, Centre Hospitalier Universitaire d'Angers, Université d'Angers, INSERM, Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers, Angers, France., Cornillet-Lefebvre P; Laboratoire d'Hématologie, Centre Hospitalier Universitaire de Reims, Reims, France., Delaunay J; Département d'Hématologie, Centre Hospitalier Universitaire de Nantes, Nantes, France., Récher C; Département d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopôle, Université Toulouse III Paul Sabatier, Toulouse, France., Delabesse E; Laboratoire d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopôle, Université Toulouse III Paul Sabatier, Toulouse, France., Pigneux A; Département d'Hématologie et Thérapie Cellulaire, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France., Vey N; Département d'hématologie, Centre de Recherche en Cancérologie de Marseille, INSERM U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille Université UM105, Marseille, France., Chretien AS; Equipe Immunité et Cancer, Centre de Recherche en Cancérologie de Marseille, INSERM U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille Université, UM105, Marseille, France.; Plateforme d'immunomonitoring, Institut Paoli-Calmettes, Marseille, France., Olive D; Equipe Immunité et Cancer, Centre de Recherche en Cancérologie de Marseille, INSERM U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille Université, UM105, Marseille, France.; Plateforme d'immunomonitoring, Institut Paoli-Calmettes, Marseille, France.
Publikováno v: Blood advances [Blood Adv] 2024 Aug 27; Vol. 8 (16), pp. 4262-4275.
Zobrazit plný text záznamu
8
Akademický článek
Childhood myelodysplastic syndromes: Is cytoreductive therapy useful before allogeneic hematopoietic stem cell transplantation?
Autor: Le Calvez B; Department of Pediatric Hematology CHU Hôtel Dieu Nantes France.; CRCI2NA, INSERM U1307, CNRS Université d'Angers/Université de Nantes France., Jullien M; Department of Clinical Hematology CHU Hôtel Dieu Nantes France., Dalle JH; Department of Pediatric Hematology, Robert Debré Hospital GHU APHPNOrd-Université Paris Cité Paris France., Renard C; Department of Pediatric Hematology IHOPe, HCL Lyon Lyon France., Jubert C; Department of Pediatric Hematology Oncology F-33000 Bordeaux Bordeaux France.; Department of Pediatric Hematology CHU de Bordeaux Bordeaux France., Sterin A; Department of Pediatric Hematology La Timone APHM, Marseille France., Paillard C; Department of Pediatric Hematology Strasbourg France., Huynh A; Department of Hematology CHU/IUCT Oncopole Toulouse Toulouse France., Guenounou S; Department of Hematology CHU/IUCT Oncopole Toulouse Toulouse France., Bruno B; Department of Pediatric Hematology Hôpital Jeanne de Flandre, CHRU Lille Lille France., Gandemer V; Department of Pediatric OncoHematology Rennes University Hospital, University of Rennes Rennes France., Buchbinder N; Department of Pediatric Hematology Hopital Charles Nicolle CHU Rouen Tunis Tunisia., Simon P; Department of Pediatric Hematology CHRU de Besancon Besancon France., Pochon C; Department of Pediatric Hematology CHRU de Nancy Nancy France., Sirvent A; Department of Pediatric Hematology CHU de Montpellier Montpellier France., Plantaz D; Department of Pediatric Hematology CHU Grenoble Alpes Grenoble La Tronche France., Kanold J; Department of Pediatric Hematology CHU de Clermont Ferrand Clermont-Ferrand France., Béné MC; CRCI2NA, INSERM U1307, CNRS Université d'Angers/Université de Nantes France.; Faculty of Medicine Nantes University Nantes France., Rialland F; Department of Pediatric Hematology CHU Hôtel Dieu Nantes France.; CICFEA, CHU de Nantes Nantes France., Grain A; Department of Pediatric Hematology CHU Hôtel Dieu Nantes France.; CRCI2NA, INSERM U1307, CNRS Université d'Angers/Université de Nantes France.; CICFEA, CHU de Nantes Nantes France.
Publikováno v: HemaSphere [Hemasphere] 2024 Jul 08; Vol. 8 (7), pp. e120. Date of Electronic Publication: 2024 Jul 08 (Print Publication: 2024).
Zobrazit plný text záznamu
9
Akademický článek
Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamide.
Autor: Jullien M; Hematology Department, Nantes University Hospital, Nantes, France.; Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.; LabEx IGO 'Immunotherapy, Graft, Oncology', Nantes, France., Guillaume T; Hematology Department, Nantes University Hospital, Nantes, France.; Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.; LabEx IGO 'Immunotherapy, Graft, Oncology', Nantes, France., Le Bourgeois A; Hematology Department, Nantes University Hospital, Nantes, France., Peterlin P; Hematology Department, Nantes University Hospital, Nantes, France., Garnier A; Hematology Department, Nantes University Hospital, Nantes, France., Eveillard M; Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.; LabEx IGO 'Immunotherapy, Graft, Oncology', Nantes, France.; Hematology Biology, Nantes University Hospital, Nantes, France., Le Bris Y; Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.; LabEx IGO 'Immunotherapy, Graft, Oncology', Nantes, France.; Hematology Biology, Nantes University Hospital, Nantes, France., Bouzy S; Hematology Biology, Nantes University Hospital, Nantes, France., Tessoulin B; Hematology Department, Nantes University Hospital, Nantes, France., Gastinne T; Hematology Department, Nantes University Hospital, Nantes, France., Dubruille V; Hematology Department, Nantes University Hospital, Nantes, France., Touzeau C; Hematology Department, Nantes University Hospital, Nantes, France., Mahé B; Hematology Department, Nantes University Hospital, Nantes, France., Blin N; Hematology Department, Nantes University Hospital, Nantes, France., Lok A; Hematology Department, Nantes University Hospital, Nantes, France., Vantyghem S; Hematology Department, Nantes University Hospital, Nantes, France., Sortais C; Hematology Department, Nantes University Hospital, Nantes, France., Antier C; Hematology Department, Nantes University Hospital, Nantes, France., Moreau P; Hematology Department, Nantes University Hospital, Nantes, France., Scotet E; Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.; LabEx IGO 'Immunotherapy, Graft, Oncology', Nantes, France., Béné MC; Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.; LabEx IGO 'Immunotherapy, Graft, Oncology', Nantes, France.; Hematology Biology, Nantes University Hospital, Nantes, France., Chevallier P; Hematology Department, Nantes University Hospital, Nantes, France.; Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.; LabEx IGO 'Immunotherapy, Graft, Oncology', Nantes, France.
Publikováno v: American journal of hematology [Am J Hematol] 2024 Mar; Vol. 99 (3), pp. 350-359. Date of Electronic Publication: 2024 Jan 02.
Zobrazit plný text záznamu
10
Akademický článek
Prognostic value of postinduction medullary myeloid recovery by flow cytometry in acute myeloid leukemia.
Autor: Row C; Service d'Hématologie Biologique CHU de Dijon Dijon France.; University of Burgundy-ISITE-BFC-Institut National de la Santé et de la Recherche Médicale (Inserm) UMR1231 Faculty of Medicine Dijon France., Lechevalier N; Service d'Hématologie Biologique CHU de Bordeaux Bordeaux France., Vial JP; Service d'Hématologie Biologique CHU de Bordeaux Bordeaux France., Mimoun A; Service d'Hématologie Biologique CHU de Bordeaux Bordeaux France., Bastie JN; Service d'Hématologie Clinique CHU de Dijon Dijon France.; University of Burgundy-ISITE-BFC-Institut National de la Santé et de la Recherche Médicale (Inserm) UMR1231 Faculty of Medicine Dijon France., Lafon I; Service d'Hématologie Biologique CHU de Bordeaux Bordeaux France., Pigneux A; Service d'Hématologie Clinique et de Thérapie Cellulaire CHU de Bordeaux Bordeaux France., Leguay T; Service d'Hématologie Clinique et de Thérapie Cellulaire CHU de Bordeaux Bordeaux France., Callanan M; University of Burgundy-ISITE-BFC-Institut National de la Santé et de la Recherche Médicale (Inserm) UMR1231 Faculty of Medicine Dijon France., Maynadie M; Service d'Hématologie Biologique CHU de Dijon Dijon France.; University of Burgundy-ISITE-BFC-Institut National de la Santé et de la Recherche Médicale (Inserm) UMR1231 Faculty of Medicine Dijon France., Béné MC; CRCI2NA INSERM UMR 1307 & CNRS UMR 6075 Université de Nantes Nantes France., Dumas PY; Service d'Hématologie Biologique CHU de Bordeaux Bordeaux France., Guy J; Service d'Hématologie Biologique CHU de Dijon Dijon France.; University of Burgundy-ISITE-BFC-Institut National de la Santé et de la Recherche Médicale (Inserm) UMR1231 Faculty of Medicine Dijon France.
Publikováno v: EJHaem [EJHaem] 2024 Jan 10; Vol. 5 (1), pp. 84-92. Date of Electronic Publication: 2024 Jan 10 (Print Publication: 2024).
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje